Cancer screening is an essential public health intervention for diagnosing cancers at an early stage that can enable earlier treatment — ideally with curative intent — and thus lead to improved outcomes. Over the past decade, liquid biopsy-based tests have emerged as a promising, minimally invasive and broadly applicable screening approach by combining multi-cancer early detection (MCED) with tumour tissue-of-origin identification. Large-scale randomized clinical trials evaluating liquid biopsy-based MCED approaches are now under way, although whether the diagnostic performance of this first generation of MCED tests is sufficient to translate into clinical benefits remains to be determined. In this Review, we discuss the promises and pitfalls of current MCED tests and highlight possible trajectories for the field of early cancer detection.
Wan, J.C.M., Sasieni, P. & Rosenfeld, N. Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.
Nat Rev Clin Oncol (2025).
.adsslot_M231cADPwd{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_M231cADPwd{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_M231cADPwd{ width:320px !important; height:50px !important; } }
ADVERTISEMENT
bu içeriği en az 2500 kelime olacak şekilde ve alt başlıklar ve madde içermiyecek şekilde ünlü bir science magazine için İngilizce olarak yeniden yaz. Teknik açıklamalar içersin ve viral olacak şekilde İngilizce yaz. Haber dışında başka bir şey içermesin. Haber içerisinde en az 14 paragraf ve her bir paragrafta da en az 80 kelime olsun. Cevapta sadece haber olsun. Ayrıca haberi yazdıktan sonra içerikten yararlanarak aşağıdaki başlıkların bilgisi var ise haberin altında doldur. Eğer bilgi yoksa ilgili kısmı yazma.:
Subject of Research:
Article Title:
Article References:
Wan, J.C.M., Sasieni, P. & Rosenfeld, N. Promises and pitfalls of multi-cancer early detection using liquid biopsy tests.
Nat Rev Clin Oncol (2025). https://doi.org/10.1038/s41571-025-01033-x
Image Credits: AI Generated
DOI:
Keywords:
Tags: cancer screening advancementscancer treatment outcomesClinical Trials in Oncologydiagnostic performance of MCEDfuture of cancer screening technologiesliquid biopsy testsminimally invasive cancer diagnosticsmulti-cancer early detectionpitfalls of liquid biopsypromises of early cancer detectionpublic health interventions for cancertumor tissue identification
